NCT06462794CX-801pembrolizumab
…ination with pembrolizumab in patients with advanced melanoma ( NCT06462794). Key objectives include safety, PD, PK, and preliminary effica…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT06462794 ×
NCT06462794
This institution is selected. Its supporting articles are shown below.